Scott Smith

Scott Andrew Smith is Chief Executive Officer & Director at Viatris, Inc. since 2023.
Mr. Smith is Director at Biotechnology Innovation Organization since 2017, Director at BioAtla, Inc. since 2018, Director at Apexigen America, Inc. since 2019, and Director at Himalaya Therapeutics.
Former roles include Chairman at F-Star Therapeutics, Inc. (United States) from 2019 to 2020, Chairman at Triumvira Immunologics, Inc. from 2017 to 2020, Chairman at Triumvira Immunologics USA, Inc., Independent Director at Titan Pharmaceuticals, Inc. from 2017 to 2021, Director at Aitia, Inc., Independent Director at Apexigen, Inc. from 2019 to 2023, Director at Refuge Biotechnologies, Inc. from 2018 to 2022, President & Chief Operating Officer at Celgene Corp.
from 2017 to 2018, Vice President-Sales at Pharmacia Corp., Vice President-Marketing at Pharmacia SAS, Vice President & General Manager at Biovail Pharmaceuticals LLC from 2003 to 2008, Vice President at Pharmacia Canada, Inc., Head-South East Asia Region at Parke Davis Ltd., and General Manager at Biovail Pharmaceuticals Canada from 2003 to 2008.
Education includes graduate degree from Thunderbird School of Global Management and undergraduate degree from the University of Western Ontario.